Exhibit 15.2



SCHEDULE 11



NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



John Stocker



|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Greenwood Nominees Limited



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|6) | Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration



|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



1,028



|8) | Percentage of issued class
|-- | --------------------------



|0.003% | 
|------ | 



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



Nil



|10) | Percentage of issued class
|--- | --------------------------



Nil



|11) | Class of security
|--- | -----------------



Ordinary 10 pence shares



|12) | Price per share
|--- | ---------------



£5.935



|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



81,979



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.199%





---

If a director has been granted options by the company please complete the following boxes



|17) | Date of grant
|--- | -------------







|18) | Period during which or date on which exercisable
|--- | ------------------------------------------------







|19) | Total amount paid (if any) for grant of the option
|--- | --------------------------------------------------







|20) | Description of shares or debentures involved: class, number
|--- | -----------------------------------------------------------







|21) | Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
|--- | ------------------------------------------------------------------------------------------------------







|22) | Total number of shares or debentures over which options held following this notification
|--- | ----------------------------------------------------------------------------------------







|23) | Any additional information
|--- | --------------------------







|24) | Name of contact and telephone number for queries
|--- | ------------------------------------------------



Justin Hoskins, 01223 898589



|25) | Name and signature of authorised company official responsible for making this notification
|--- | ------------------------------------------------------------------------------------------







Date of Notification 26 November 2004



SCHEDULE 11



NOTIFICATION OF INTERESTS OF
DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



Ake Stavling



|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Greenwood Nominees Limited



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|6) | Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration



|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



1,028



|8) | Percentage of issued class
|-- | --------------------------



0.003%



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



Nil





---

|10) | Percentage of issued class
|--- | --------------------------



|Nil | 
|--- | 



|11) | Class of security
|--- | -----------------



Ordinary 10 pence shares



|12) | Price per share
|--- | ---------------



£5.935



|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



2,135



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.005%



If a director has been granted options by the company please complete the following boxes



|17) | Date of grant
|--- | -------------







|18) | Period during which or date on which exercisable
|--- | ------------------------------------------------







|19) | Total amount paid (if any) for grant of the option
|--- | --------------------------------------------------







|20) | Description of shares or debentures involved: class, number
|--- | -----------------------------------------------------------







|21) | Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
|--- | ------------------------------------------------------------------------------------------------------







|22) | Total number of shares or debentures over which options held following this notification
|--- | ----------------------------------------------------------------------------------------







|23) | Any additional information
|--- | --------------------------







|24) | Name of contact and telephone number for queries
|--- | ------------------------------------------------



Justin Hoskins, 01223 898589



|25) | Name and signature of authorised company official responsible for making this notification
|--- | ------------------------------------------------------------------------------------------







Date of Notification 26 November 2004



SCHEDULE 11



NOTIFICATION OF INTERESTS OF
DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



Sir Aaron Klug





---

|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Greenwood Nominees Limited



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|6) | Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration



|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



1,028



|8) | Percentage of issued class
|-- | --------------------------



0.003%



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



Nil



|10) | Percentage of issued class
|--- | --------------------------



Nil



|11) | Class of security
|--- | -----------------



Ordinary 10 pence shares



|12) | Price per share
|--- | ---------------



£5.935



|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



31,307



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.076%



If a director has been granted options by the company please complete the following boxes



|17) | Date of grant
|--- | -------------







|18) | Period during which or date on which exercisable
|--- | ------------------------------------------------







|19) | Total amount paid (if any) for grant of the option
|--- | --------------------------------------------------







|20) | Description of shares or debentures involved: class, number
|--- | -----------------------------------------------------------







|21) | Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
|--- | ------------------------------------------------------------------------------------------------------





---

|22) | Total number of shares or debentures over which options held following this notification
|--- | ----------------------------------------------------------------------------------------







|23) | Any additional information
|--- | --------------------------







|24) | Name of contact and telephone number for queries
|--- | ------------------------------------------------



Justin Hoskins, 01223 898589



|25) | Name and signature of authorised company official responsible for making this notification
|--- | ------------------------------------------------------------------------------------------







Date of Notification 26 November 2004



SCHEDULE 11



NOTIFICATION OF INTERESTS OF
DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



Peter Ringrose



|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Greenwood Nominees Limited



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|6) | Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration



|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



1,028



|8) | Percentage of issued class
|-- | --------------------------



0.003%



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



|Nil | 
|--- | 



|10) | Percentage of issued class
|--- | --------------------------



|Nil | 
|--- | 



|11) | Class of security
|--- | -----------------



|Ordinary | 10 pence shares
|-------- | ---------------



|12) | Price per share
|--- | ---------------



|£5.935 | 
|------ | 





---

|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



2,955



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.007%



If a director has been granted options by the company please complete the following boxes



|17) | Date of grant
|--- | -------------







|18) | Period during which or date on which exercisable
|--- | ------------------------------------------------







|19) | Total amount paid (if any) for grant of the option
|--- | --------------------------------------------------







|20) | Description of shares or debentures involved: class, number
|--- | -----------------------------------------------------------







|21) | Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
|--- | ------------------------------------------------------------------------------------------------------







|22) | Total number of shares or debentures over which options held following this notification
|--- | ----------------------------------------------------------------------------------------







|23) | Any additional information
|--- | --------------------------







|24) | Name of contact and telephone number for queries
|--- | ------------------------------------------------



Justin Hoskins, 01223 898589



|25) | Name and signature of authorised company official responsible for making this notification
|--- | ------------------------------------------------------------------------------------------







Date of Notification 26 November 2004



SCHEDULE 11



NOTIFICATION OF INTERESTS OF
DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



Professor Christopher Marshall



|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Greenwood Nominees Limited



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above





---

|6) | Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration



|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



20



|8) | Percentage of issued class
|-- | --------------------------



0.00005%



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



Nil



|10) | Percentage of issued class
|--- | --------------------------



|Nil | 
|--- | 



|11) | Class of security
|--- | -----------------



|Ordinary | 10 pence shares
|-------- | ---------------



|12) | Price per share
|--- | ---------------



|£5.935 | 
|------ | 



|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



20



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.00005%



SCHEDULE 11



NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



Dr Paul Nicholson



|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Dr Paul Nicholson



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|6) | Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration





---

|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



2,019



|8) | Percentage of issued class
|-- | --------------------------



0.0005%



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



Nil



|10) | Percentage of issued class
|--- | --------------------------



Nil



|11) | Class of security
|--- | -----------------



Ordinary 10 pence shares



|12) | Price per share
|--- | ---------------



£5.935



|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



9,112



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.022%



If a director has been granted options by the company please complete the following boxes



|17) | Date of grant
|--- | -------------







|18) | Period during which or date on which exercisable
|--- | ------------------------------------------------







|19) | Total amount paid (if any) for grant of the option
|--- | --------------------------------------------------







|20) | Description of shares or debentures involved: class, number
|--- | -----------------------------------------------------------







|21) | Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
|--- | ------------------------------------------------------------------------------------------------------







|22) | Total number of shares or debentures over which options held following this notification
|--- | ----------------------------------------------------------------------------------------







|23) | Any additional information
|--- | --------------------------







|24) | Name of contact and telephone number for queries
|--- | ------------------------------------------------



Justin Hoskins, 01223 898589



|25) | Name and signature of authorised company official responsible for making this notification
|--- | ------------------------------------------------------------------------------------------







Date of Notification 26 November 2004





---

SCHEDULE 11



NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS



|1) | Name of company
|-- | ---------------



Cambridge Antibody Technology



|2) | Name of director
|-- | ----------------



Professor Uwe Bicker



|3) | Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an
individual holder if it is a holding of that persons spouse or children under the age of 18 or in respect of a non-beneficial interest
|-- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|4) | Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them (if notified)
|-- | ----------------------------------------------------------------------------------------------------------------------



Professor Uwe Bicker



|5) | Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s)
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



As in 2 above



|6) | Please stats the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary
|-- | -----------------------------------------------------------------------------------------------------------------------------------------------------



Regular annual payment of part of directors fees in lieu of cash consideration



|7) | Number of shares/amount of stock acquired
|-- | -----------------------------------------



1,028



|8) | Percentage of issued class
|-- | --------------------------



0.003%



|9) | Number of shares/amount of stock disposed
|-- | -----------------------------------------



Nil



|10) | Percentage of issued class
|--- | --------------------------



Nil



|11) | Class of security
|--- | -----------------



Ordinary 10 pence shares



|12) | Price per share
|--- | ---------------



£5.935



|13) | Date of transaction
|--- | -------------------



26 November 2004



|14) | Date company informed
|--- | ---------------------



26 November 2004



|15) | Total holding following this notification
|--- | -----------------------------------------



5, 838



|16) | Total percentage holding of issued class following this notification
|--- | --------------------------------------------------------------------



0.014%



If a director has been granted options by the company please complete the following boxes



|17) | Date of grant
|--- | -------------







|18) | Period during which or date on which exercisable
|--- | ------------------------------------------------





---

|19) | Total amount paid (if any) for grant of the option
|--- | --------------------------------------------------







|20) | Description of shares or debentures involved: class, number
|--- | -----------------------------------------------------------







|21) | Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise
|--- | ------------------------------------------------------------------------------------------------------







|22) | Total number of shares or debentures over which options held following this notification
|--- | ----------------------------------------------------------------------------------------







|23) | Any additional information
|--- | --------------------------







|24) | Name of contact and telephone number for queries
|--- | ------------------------------------------------



Justin Hoskins, 01223 898589



|25) | Name and signature of authorised company official responsible for making this notification
|--- | ------------------------------------------------------------------------------------------







Date of Notification 26 November 2004



END